A conference on 1 July will provide an update on the UK Medicines
and Healthcare products Regulatory Agency Best Practice Guidance on
the Labelling and Packaging of Medicines
The UK's Medicines and Healthcare products Regulatory Agency has
asked for prescribing restrictions on GlaxoSmithKline's
widely-prescribed antidepressant Seroxat.